14159 capital (GP), LLC Insider Trading $TZYM Ocera Therapeutics, Inc.
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
14159 capital (GP), LLC in Ocera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 57,704 shares
Latest Transaction: Mar 14 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of 14159 capital (GP), LLC in Ocera Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, GHDX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 3.01 | 910 | 2,735 | 57,704 | 56.8 K to 57.7 K (+1.60 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.99 | 1,482 | 4,430 | 56,794 | 55.3 K to 56.8 K (+2.68 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.96 | 4,186 | 12,383 | 55,312 | 51.1 K to 55.3 K (+8.19 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.55 | 15,076 | 38,444 | 51,126 | 36.1 K to 51.1 K (+41.82 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.34 | 8,628 | 20,186 | 36,050 | 27.4 K to 36.1 K (+31.46 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.87 | 1,170 | 2,188 | 27,422 | 26.3 K to 27.4 K (+4.46 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.89 | 430 | 811 | 26,252 | 25.8 K to 26.3 K (+1.67 %) |
Page: 1